Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 1, 2004

Review article

Favourites:
ADD

Angiogenesis Inhibitors: Current & Future Directions
pp. 1-9(9)
Authors: Mousa, Shaker A.; Mousa, Ahmed S.

Favourites:
ADD

Angiogenesis: A Target for Cancer Therapy
pp. 11-26(16)
Authors: Tortora, Giampaolo; Melisi, Davide; Ciardiello, Fortunato

Favourites:
ADD

Antiangiogenic Therapy
pp. 27-37(11)
Authors: Albo, Daniel; Wang, Thomas N.; Tuszynski, George P.

Favourites:
ADD

The Urokinase Plasminogen Activator System: Role in Malignancy
pp. 39-49(11)
Author: Duffy, Michael J.

Favourites:
ADD

Resistance to Anti-VEGF Agents
pp. 51-64(14)
Authors: C., Ton N.; C., Jayson G.

Favourites:
ADD

Molecular Targeting of Lymphatics for Therapy
pp. 65-74(10)
Authors: Stacker, S. A.; Hughes, R. A.; Achen, M. G.

Favourites:
ADD

Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications
pp. 75-80(6)
Authors: Wilting, Jorg; Schweigerer, Lothar

Favourites:
ADD

Addendum

Author Index to Volume 9
pp. 81-87(7)
Author: Bentham Science Publishers

Favourites:
ADD

Subject Index to Volume 9
pp. 89-108(20)
Author: Bentham Science Publishers

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content